Abstract
Objective: The objective was to describe the prevalence, clinical manifestations, and associated factors of long COVID-19. Methods: A bibliographic search of systematic reviews and meta-analyses on long COVID-19 was carried out in MEDLINE (via PubMed) up to April 7th, 2022. 37 articles were found and 3 were included. Results: The quality of the evidence was evaluated through AMSTAR 2 criteria. The reported prevalence of long COVID- 19 was 43% (95% CI: 39% - 46%). The main clinical manifestations were weakness (41% [95% CI: 25% - 59%]), malaise (33% [95% CI: 15% - 57%]), fatigue (31% [95% CI: 24% - 39% %]), changes in concentration (26% [95% CI: 21% - 32%]) and shortness of breath (25% [95% CI: 18% - 34%]). Conclusion: Factors associated with long COVID-19 include female gender, the severity of initial symptoms, age, and the presence of comorbidities.
Translated title of the contribution | PREVALENCIA, MANIFESTACIONES CLÍNICAS Y FACTORES ASOCIADOS AL COVID-19 DE LARGA DURACIÓN |
---|---|
Original language | English |
Pages (from-to) | 556-567 |
Number of pages | 12 |
Journal | Revista de la Facultad de Medicina Humana |
Volume | 22 |
Issue number | 3 |
DOIs | |
State | Published - 1 Jul 2022 |
Externally published | Yes |
Keywords
- COVID-19
- Long COVID-19
- Post-acute COVID-19 syndrome